IBC Oxford Poster Abstract 2 - Efficacy of intragastric balloon on weight reduction

Introduction Intragastric balloon (IGB) is a space occupying device which leads to weight loss reducing gastric capacity and inducing satiety. IGB is an option for weight reduction as a primary treatment or as a bridge to bariatric surgery. Aim The aim of this study was to evaluate the safety and efficacy of fluid filled intragastric balloon in weight reduction in patients at the surgical endoscopy unit. Methods This is a retrospective monocentric study involving all patients who opted for fluid filled intragastric balloon placement. Patients were followed up after 6 and 12 months after intragastric balloon implantation. Results A total of 90 patients were included in this study, with 69 (76.7%) women and 21 (23.3%) men. The mean age was 34.3 years and 60% were fluid filled adjustable balloons. Body mass index (BMI) was 31.9 kg/m²; body mass index decreased to 28.9 kg/m². The mean percentage of total body weight loss (TBWL) was 17.10% + 8.30% and the percentage of excess weight loss (EWL) was 81.10% + 60.05%. For EWL calculation purposes, the ideal weight was considered the one corresponding to a BMI of 25 kg/m². No serious adverse events (SAE) were reported. The early removal rate due to intolerance was 4.4% (4/90). Conclusion Intragastric fluid filled balloon shows good tolerance. IGB is safe and effective for weight loss comparable to published literature.